-
EP1641445
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP1641445
| EP1641445 - USE OF ALVERINE, ALONE OR IN COMBINATION WITH A TRICYCLIC ANTIDEPRESSANT OR AN ANTIDEPRESSANT WHICH IS A SPECIFIC INHIBITOR OF SEROTONIN REUPTAKE FOR TREATMENT OF DEPRESSION [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 16.05.2008 Database last updated on 19.07.2024 | Most recent event Tooltip | 16.05.2008 | Application deemed to be withdrawn | published on 18.06.2008 [2008/25] | Applicant(s) | For all designated states CEREP 155, Boulevard Haussmann 75008 Paris / FR | [N/P] |
| Former [2006/14] | For all designated states Cerep 155, Boulevard Haussmann 75008 Paris / FR | Inventor(s) | 01 /
MIGEON, Jacques 2349 N. 57th Street 98103 Seattle / US | 02 /
REVAH, Frédéric 14, rue George Ville F-75116 Paris / FR | [2006/14] | Representative(s) | Warcoin, Jacques, et al Cabinet Regimbeau 20, rue de Chazelles 75847 Paris Cedex 17 / FR | [N/P] |
| Former [2006/14] | Warcoin, Jacques, et al Cabinet Régimbeau 20, rue de Chazelles 75847 Paris cedex 17 / FR | Application number, filing date | 04767327.2 | 11.06.2004 | [2006/14] | WO2004FR01462 | Priority number, date | FR20030007176 | 13.06.2003 Original published format: FR 0307176 | FR20040004639 | 30.04.2004 Original published format: FR 0404639 | [2006/14] | Filing language | FR | Procedural language | FR | Publication | Type: | A1 Application with search report | No.: | WO2005002560 | Date: | 13.01.2005 | Language: | FR | [2005/02] | Type: | A1 Application with search report | No.: | EP1641445 | Date: | 05.04.2006 | Language: | FR | The application published by WIPO in one of the EPO official languages on 13.01.2005 takes the place of the publication of the European patent application. | [2006/14] | Search report(s) | International search report - published on: | EP | 13.01.2005 | Classification | IPC: | A61K31/137, A61K31/55, A61K31/138, A61P25/24 | [2006/14] | CPC: |
A61K31/137 (EP,US);
A61K31/138 (EP,US);
A61K31/55 (EP,US);
A61P25/24 (EP);
A61P43/00 (EP)
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LI, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR [2006/14] | Extension states | AL | Not yet paid | HR | Not yet paid | LT | Not yet paid | LV | Not yet paid | MK | Not yet paid | Title | German: | VERWENDUNG VON ALVERIN, ALLEIN ODER IN KOMBINATION MIT EINEM TRICYCLISCHEN ANTIDEPRESSIVUM ODER EINEM ANTIDEPRESSIVUM ALS SPEZIFISCHER HEMMER DER SEROTONIN-WIEDERAUFNAHME ZUR BEHANDLUNG VON DEPRESSION | [2006/14] | English: | USE OF ALVERINE, ALONE OR IN COMBINATION WITH A TRICYCLIC ANTIDEPRESSANT OR AN ANTIDEPRESSANT WHICH IS A SPECIFIC INHIBITOR OF SEROTONIN REUPTAKE FOR TREATMENT OF DEPRESSION | [2006/14] | French: | UTILISATION DE L'ALVERINE, SEUL OU EN COMBINAISON AVEC UN ANTIDEPRESSEUR TRICYCLIQUE OU UN ANTIDEPRESSEUR INHIBITEUR SPECIFIQUE DE LA RECAPTURE DE LA SEROTONINE POUR LE TRAITEMENT DE LA DEPRESSION | [2006/14] | Entry into regional phase | 05.01.2006 | National basic fee paid | 05.01.2006 | Designation fee(s) paid | 05.01.2006 | Examination fee paid | Examination procedure | 05.01.2006 | Examination requested [2006/14] | 02.01.2008 | Application deemed to be withdrawn, date of legal effect [2008/25] | 04.02.2008 | Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time [2008/25] | Fees paid | Renewal fee | 05.01.2006 | Renewal fee patent year 03 | Penalty fee | Additional fee for renewal fee | 30.06.2007 | 04 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [Y]US6239126 (KELLY MICHAEL G [US], et al) [Y] 1-18 * colonne 1, ligne 22-34; revendication 12 *; | [Y]GB2272155 (WYETH JOHN & BROTHER LTD [GB]) [Y] 1-18 * page 5, lignes 1-7 *; | [DY]WO9202488 (NORGINE LTD [GB]) [DY] 1-18 * claims 1-17 *; | [A]FR2798590 (OREAL [FR]) [A] 1-6 * rev. 1-9 * | [Y] - COELHO ANNE-MARIE ET AL, "Rectal antinociceptive properties of alverine citrate are linked to antagonism at the 5-HT1A receptor subtype", JOURNAL OF PHARMACY AND PHARMACOLOGY, &, (200110), vol. 53, no. 10, ISSN 0022-3573, pages 1419 - 1426, XP009025660 [Y] 1-18 * table 2 * DOI: http://dx.doi.org/10.1211/0022357011777783 |